Filing Details
- Accession Number:
- 0001415889-21-004306
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-09 16:25:20
- Reporting Period:
- 2021-09-07
- Accepted Time:
- 2021-09-09 16:25:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1750284 | Olema Pharmaceuticals Inc. | OLMA | Pharmaceutical Preparations (2834) | 300409740 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1831218 | Sean Bohen | C/O Olema Pharmaceuticals, Inc. 512 2Nd Street, 4Th Floor San Francisco CA 94107 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-07 | 413 | $4.82 | 54,687 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-09-07 | 413 | $30.08 | 54,274 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-09-08 | 2,631 | $4.82 | 56,905 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-09-08 | 2,631 | $30.00 | 52,514 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-09-07 | 413 | $0.00 | 413 | $4.82 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-09-08 | 2,631 | $0.00 | 2,631 | $4.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 975,032 | 2030-11-18 | No | 4 | M | Direct | |
| 972,401 | 2030-11-18 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- The weighted average sale price for the transaction reported was $30.08, and the range of prices were between $30.00 and $30.12. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- (A) 256,992 of the shares subject to the option vest on September 1, 2021, (B) 2,411 of the shares subject to the option vest on January 1, 2022 and 2,410 of the shares subject to the option vest on January 1 of each of 2023 and 2024 and (C) 23,143 of the shares subject to the option vest on the 1st day of each month (other than on September 1, 2021 and each of January 1, 2022, 2023 and 2024) following September 1, 2021, plus an additional 23 shares on September 1, 2024. Subject to, in each case of (A) - (C) above, the Reporting Person's continuous service on each applicable vesting date. The stock option is early exercisable.
Billionaire Hedge Funds
